New Guidance for Health Surveillance and Biomonitoring of Workers Exposed to Lead and Its Compounds

EU-OSHA has issued new guidance specifically addressing the health surveillance and biological monitoring of workers exposed to lead and its inorganic compounds. The guidance reflects amendments to EU legislation that lowered exposure limits for lead and establishes recommended practices for monitoring lead levels in blood and conducting medical examinations. It supplements existing biological monitoring guidance and provides detailed explanations of regulatory requirements under Directive 2004/37/EC.

Employers and occupational health professionals in industries where worker lead exposure occurs should review the guidance to ensure their biological monitoring programmes and medical surveillance procedures align with the updated recommended practices. The guidance applies to any workplace where workers may be exposed to lead or its inorganic compounds and provides a framework for OSH experts to implement compliant surveillance programmes.